Pakistan

in page functions
[French]
Pakistan
Total population (2017) 196,743,438
Birth cohort (2017) 5,482,345
Surviving Infants (surviving to 1 year per year, 2017) 5,131,327
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 81/1000
World Bank Index, IDA (2015) 3.22
Gross Nation Income (per capita US$, 2015) 1,440
Co-financing group (2018) Preparatory transition
No. of districts/territories (2016) 151

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Pakistan

Type of support

Approvals

2001-2022 (US$)
(29 May 2018)

Commitments

2001-2022 (US$)
(29 May 2018)

Disbursements

2000-2018 (US$)
(29 May 2018)

% Disbursed

(29 May 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $1,166,047,768 $1,166,047,768 $1,109,764,933
Civil Society Organisation support (CSO) $7,638,649 $7,638,649 $7,738,649 101%
Cold Chain Equipment Optimisation Platform (CCEOP) $20,555,358 $20,555,358 $7,696,069 37%
Health system strengthening (HSS 1) $23,379,207 $23,379,207 $23,379,207 100%
Health system strengthening (HSS 2) $100,000,000 $100,000,000 $59,000,000 59%
HepB mono (NVS) $24,953,324 $24,953,324 $24,953,324 100%
Immunisation services support (ISS) $48,763,740 $48,763,740 $48,763,740 100%
Injection Safety Devices (NVS) $3,833,500 $3,833,500 $4,840,943 126%
Injection safety support (INS) $7,405,082 $7,405,082 $7,405,082 100%
IPV (NVS) $18,378,580 $18,378,580 $14,317,058 78%
Measles SIA (NVS) $10,029,548 $10,029,548 $10,029,548 100%
Measles SIA - Operational costs (OPC) $21,664,500 $21,664,500 $21,664,500 100%
Penta (NVS) $377,434,394 $377,434,394 $382,520,050 101%
Pneumo (NVS) $420,461,605 $420,461,605 $430,184,350 102%
Rotavirus (NVS) $34,546,000 $34,546,000 $20,527,831 59%
Tetra DTP-HepB (NVS) $31,387,734 $31,387,734 $31,387,734 100%
Vaccine Introduction Grant (VIG) $15,616,547 $15,616,547 $15,356,848 98%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Pakistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 86%
M:F sex ratio at birth (2017) 1.09
Household survey: DTP3 coverage for male (2012) 67.20%
Household survey: DTP3 coverage for female (2012) 63.10%
Household survey: Last DTP3 survey (2012) 78%
% districts achieving > 80% DTP3 coverage (2016) 64%
% districts achieving < 50% DTP3 coverage (2016) 9%
MCV WHO/UNICEF estimates (2016) 61%

Breakdown of support

Non-vaccine support Vaccine support
17% 83%
$191,004,095 $918,760,838

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Pakistan

07 June 2018

IPV DRC 2015

Gavi Board approves funding for inactivated poliovirus vaccine until 2020

Flexible support to Nigeria and post-transition countries also approved.

07 March 2018

Female vaccine heroes: two health workers, two scientists, a teacher and a town crier

If you know something about global health, you’ve probably heard of Edward Jenner or Jonas Salk, but what about the women who also helped lay the foundations for modern immunisation? Meet five remarkable women who pushed forward the frontiers of science.

07 March 2018

IWD Sri Lanka

How breaking gender barriers can increase immunisation coverage

Immunisation is generally known as one of the most gender-equal health interventions. But did you know that empowering women means more children – both boys and girls – get access to vaccines?

close icon

modal window here